DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Aptose Biosciences Q4 EPS $(0.13) Beats $(0.15) Estimate

Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 23.53 percent increase over losses of $(0.17) per share

Benzinga · 03/10/2020 20:03

Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 23.53 percent increase over losses of $(0.17) per share from the same period last year.